From HLA typing to anti-HLA antibody detection and beyond: The road ahead

Dyer, 2013, Status report from 'double agent HLA': health and disease, Mol Immunol, 55, 2, 10.1016/j.molimm.2012.08.016 Mosaad, 2015, Clinical role of human leukocyte antigen in health and disease, Scand J Immunol, 82, 283, 10.1111/sji.12329 Shiina, 2009, The HLA genomic loci map: expression, interaction, diversity and disease, J Hum Genet, 54, 15, 10.1038/jhg.2008.5 Marsh, 2010, Nomenclature for factors of the HLA system, Tissue Antigens, 75, 291, 10.1111/j.1399-0039.2010.01466.x Robinson, 2015, The IPD and IMGT/HLA database: allele variant databases, Nucleic Acids Res, 43, D423, 10.1093/nar/gku1161 Mack, 2013, Common and well-documented HLA alleles: 2012 update to the CWD catalogue, Tissue Antigens, 81, 194, 10.1111/tan.12093 Süsal, 2013, Current role of human leukocyte antigen matching in kidney transplantation, Curr Opin Organ Transplant, 18, 438, 10.1097/MOT.0b013e3283636ddf Tiercy, 2013, Impact of HLA diversity on donor selection in organ and stem cell transplantation, Hum Hered, 76, 178, 10.1159/000358798 Picascia, 2014, Lights and shadows of anti-HLA antibodies detected by solid-phase assay, Immunol Lett, 162, 181, 10.1016/j.imlet.2014.08.014 Picascia, 2014, Human leukocyte antigens and alloimmunization in heart transplantation: an open debate, J Cardiovasc Transl Res, 7, 664, 10.1007/s12265-014-9587-z Opelz, 2007, Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades, Transplantation, 84, 137, 10.1097/01.tp.0000269725.74189.b9 Meier-Kriesche, 2009, A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients, Transplantation, 88, 23, 10.1097/TP.0b013e3181a9ec89 Napoli, 2014, Long-term follow-up of kidney transplants in a region of southern Italy, Exp Clin Transplant, 12, 15, 10.6002/ect.2013.0116 Eng, 2011, Histocompatibility testing after fifty years of transplantation, J Immunol Methods, 369, 1, 10.1016/j.jim.2011.04.005 Dunn, 2015, Novel approaches and technologies in molecular HLA typing, Methods Mol Biol, 1310, 213, 10.1007/978-1-4939-2690-9_18 Olerup, 1991, HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique, Tissue Antigens, 37, 197, 10.1111/j.1399-0039.1991.tb01872.x Hoshino, 1991, Polymerase chain reaction—single-strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: a simple, economical, and rapid method for histocompatibility testing, Hum Immunol, 33, 98, 10.1016/0198-8859(92)90059-V Testi, 2015, Luminex-based methods in high-resolution HLA typing, Methods Mol Biol, 1310, 231, 10.1007/978-1-4939-2690-9_19 Zhang, 2014, Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis, Front Immunol, 5, 597, 10.3389/fimmu.2014.00597 Danzer, 2007, High-throughput sequence- based typing strategy for HLA-DRB1 based on real-time polymerase chain reaction, Hum Immunol, 68, 915, 10.1016/j.humimm.2007.10.005 Fan, 2012, Rapid and reliable genotyping of HLA-B*27 in the Chinese Han population using a duplex real-time TaqMan PCR assay, Clin Biochem, 45, 106, 10.1016/j.clinbiochem.2011.11.005 Goris, 2008, A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele, Tissue Antigens, 72, 401, 10.1111/j.1399-0039.2008.01101.x Falasca, 2016, Comparative analysis of real-time PCR methods to typing HLA-B*57:01 in HIV-1 positive patients, AIDS Res Hum Retroviruses, 10, 654, 10.1089/aid.2015.0303 Erali, 2008, High resolution melting applications for clinical laboratory medicine, Exp Mol Pathol, 85, 50, 10.1016/j.yexmp.2008.03.012 Kim, 2011, Rapid genotyping of HLA-B27 among Korean population by real-time PCR melting curve analysis, Clin Chim Acta, 412, 1912, 10.1016/j.cca.2011.06.034 Hammond, 2007, HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay, Tissue Antigens, 70, 58, 10.1111/j.1399-0039.2007.00840.x Profaizer, 2011, Celiac disease and HLA typing using real-time PCR with melting curve analysis, Tissue Antigens, 78, 31, 10.1111/j.1399-0039.2011.01676.x Dunn, 2011, Human leucocyte antigen typing: techniques and technology, a critical appraisal, Int J Immunogenet, 38, 463, 10.1111/j.1744-313X.2011.01040.x Erlich, 2012, HLA DNA typing: past, present, and future, Tissue Antigens, 80, 1, 10.1111/j.1399-0039.2012.01881.x Adams, 2004, Ambiguous allele combinations in HLA class I and class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification, J Transl Med, 2, 30, 10.1186/1479-5876-2-30 Cano, 2007, Common and well-documented HLA alleles: report of the ad-hoc committee of the american society for histocompatiblity and immunogenetics, Hum Immunol, 68, 392, 10.1016/j.humimm.2007.01.014 Gonzalez-Galarza, 2013, HLA rare allele consortium. 16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles, Int J Immunogenet, 40, 60 Paunić, 2012, Measuring ambiguity in HLA typing methods, PLoS One, 7, e43585, 10.1371/journal.pone.0043585 De Santis, 2013, 16(th) IHIW: review of HLA typing by NGS, Int J Immunogenet, 40, 72, 10.1111/iji.12024 Metzker, 2010, Sequencing technologies - the next generation, Nat Rev Genet, 11, 31, 10.1038/nrg2626 Duke, 2016, Determining performance characteristics of an NGS-based HLA typing method for clinical applications. HLA, HLA, 87, 141, 10.1111/tan.12736 Monos, 2015, Progressing towards the complete and thorough characterization of the HLA genes by NGS (or single-molecule DNA sequencing): consequences, opportunities and challenges, Hum Immunol, 76, 883, 10.1016/j.humimm.2015.10.003 Lind, 2010, Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing, Hum Immunol, 71, 1033, 10.1016/j.humimm.2010.06.016 Gabriel, 2014, HLA typing by next-generation sequencing - getting closer to reality, Tissue Antigens, 83, 65, 10.1111/tan.12298 Danzer, 2013, Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnostics, BMC Genomics, 14, 221, 10.1186/1471-2164-14-221 Holcomb, 2011, A multi-site study using high-resolution HLA genotyping by next generation sequencing, Tissue Antigens, 77, 206, 10.1111/j.1399-0039.2010.01606.x Moonsamy, 2013, High throughput HLA genotyping using 454 sequencing and the Fluidigm access Array™ system for simplified amplicon library preparation, Tissue Antigens, 81, 141, 10.1111/tan.12071 Yamamoto, 2015, Very high resolution single pass HLA genotyping using amplicon sequencing on the 454 next generation DNA sequencers: comparison with sanger sequencing, Hum Immunol, 76, 910, 10.1016/j.humimm.2015.05.002 Barone, 2015, HLA-genotyping of clinical specimens using ion torrent-based NGS, Hum Immunol, 76, 903, 10.1016/j.humimm.2015.09.014 Wang, 2012, High-throughput, high-fidelity HLA genotyping with deep sequencing, Proc Natl Acad Sci U S A, 109, 8676, 10.1073/pnas.1206614109 Hosomichi, 2013, Phase-defined complete sequencing of the HLA genes by next-generation sequencing, BMC Genomics, 14, 355, 10.1186/1471-2164-14-355 Mayor, 2015, HLA typing for the next generation, PLoS One, 10, e0127153, 10.1371/journal.pone.0127153 Shiina, 2012, Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers, Tissue Antigens, 80, 305, 10.1111/j.1399-0039.2012.01941.x Wittig, 2015, Development of a high-resolution NGS-based HLA-typing and analysis pipeline, Nucleic Acids Res, 43, e70, 10.1093/nar/gkv184 Nelson, 2015, An integrated genotyping approach for HLA and other complex genetic systems, Hum Immunol, 76, 928, 10.1016/j.humimm.2015.05.001 Malheiro, 2015, Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation, Transpl Immunol, 32, 66, 10.1016/j.trim.2015.01.002 Badders, 2015, Variable HLA expression on deceased donor lymphocytes: not all crossmatches are created equal, Hum Immunol, 76, 795, 10.1016/j.humimm.2015.09.029 Hönger, 2015, Inter-individual differences in HLA expression can impact the CDC crossmatch, Tissue Antigens, 85, 260, 10.1111/tan.12537 Picascia, 2012, Luminex and antibody detection in kidney transplantation, Clin Exp Nephrol, 16, 373, 10.1007/s10157-012-0635-1 Tait, 2013, Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation, Transplantation, 95, 19, 10.1097/TP.0b013e31827a19cc Israeli, 2015, ASHI proficiency testing program. Concordance and discordance in anti-HLA antibody testing, Transpl Immunol, 32, 1, 10.1016/j.trim.2014.10.003 Richter, 2016, Pre-transplant HLA antibodies detected by single antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor specific antibodies, Transpl Int, 10.1111/tri.12786 Yell, 2015, C1q binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection, Transplantation, 99, 1151, 10.1097/TP.0000000000000699 Messina, 2015, Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy, Transpl Immunol, 33, 7, 10.1016/j.trim.2015.06.002 Sicard, 2015, Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss, J Am Soc Nephrol, 26, 457, 10.1681/ASN.2013101144 Crespo, 2013, Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?, Transpl Immunol, 29, 28, 10.1016/j.trim.2013.07.002 Llorente, 2012, C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG, Transplant Proc, 44, 2535, 10.1016/j.transproceed.2012.09.084 Duquesnoy, 2014, Human leukocyte antigen epitope antigenicity and immunogenicity, Curr Opin Organ Transplant, 19, 428, 10.1097/MOT.0000000000000100 Duquesnoy, 2012, The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity, Int J Immunogenet, 39, 1, 10.1111/j.1744-313X.2011.01042.x Duquesnoy, 2015, High-resolution HLA typing for sensitized patients: advances in medicine and science require us to challenge existing paradigms, Am J Transplant, 15, 2780, 10.1111/ajt.13376 Suárez-Álvarez, 2013, Epigenetic modulation of the immune function: a potential target for tolerance, Epigenetics, 8, 694, 10.4161/epi.25201 Filippone, 2015, Humoral immune response and allograft function in kidney transplantation, Am J Kidney Dis, 66, 337, 10.1053/j.ajkd.2015.03.033 Djamali, 2014, Diagnosis and management of antibody-mediated rejection: current status and novel approaches, Am J Transplant, 14, 255, 10.1111/ajt.12589 Ong, 2015, Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine, Transplant Rev (Orlando), 29, 60, 10.1016/j.trre.2014.12.003 Mas, 2013, MicroRNAs as biomarkers in solid organ transplantation, Am J Transplant, 13, 11, 10.1111/j.1600-6143.2012.04313.x Traitanon, 2014, Molecular monitoring of alloimmune-mediated injury in kidney transplant patients, Curr Opin Nephrol Hypertens, 23, 625, 10.1097/MNH.0000000000000064 Picascia, 2015, Innate and adaptive immune response in stroke: focus on epigenetic regulation, J Neuroimmunol, 289, 111, 10.1016/j.jneuroim.2015.10.013 Picascia, 2015, Epigenetic control of autoimmune diseases: from bench to bedside, Clin Immunol, 157, 1, 10.1016/j.clim.2014.12.013 Napoli, 2016, Novel epigenetic-based therapies useful in cardiovascular medicine, World J Cardiol, 8, 211, 10.4330/wjc.v8.i2.211 Grimaldi, 2015, Epigenetic reprogramming in atherosclerosis, Curr Atheroscler Rep, 476 McCaughan, 2012, Epigenetics: time to translate into transplantation, Transplantation, 94, 1, 10.1097/TP.0b013e31824db9bd Mas, 2016, Epigenetics in kidney transplantation: current evidence, predictions, and future research directions, Transplantation, 100, 23, 10.1097/TP.0000000000000878 Parker, 2008, Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome, Transplantation, 86, 1818, 10.1097/TP.0b013e31818fe8f9 Pratt, 2006, Ischemic epigenetics and the transplanted kidney, Transplant Proc, 38, 3344, 10.1016/j.transproceed.2006.10.112 Mehta, 2006, Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation, Transplant Proc, 38, 3420, 10.1016/j.transproceed.2006.10.149 Ningappa, 2016, Enhanced B cell alloantigen presentation and its epigenetic dysregulation in liver transplant rejection, Am J Transplant, 16, 497, 10.1111/ajt.13509 van den Akker, 2015, MicroRNAs in kidney transplantation: living up to their expectations?, J Transplant, 2015, 354826, 10.1155/2015/354826 Amrouche, 2014, MicroRNAs as biomarkers of graft outcome, Transplant Rev (Orlando), 28, 111, 10.1016/j.trre.2014.03.003 Wilflingseder, 2015, Oberbauer R1. MicroRNAs in kidney transplantation, Nephrol Dial Transplant, 30, 910, 10.1093/ndt/gfu280 Soltaninejad, 2015, Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection, Transpl Immunol, 33, 1, 10.1016/j.trim.2015.05.002 Tao, 2015, Serum MicroRNA-99a helps detect acute rejection in renal transplantation, Transplant Proc, 47, 1683, 10.1016/j.transproceed.2015.04.094 Wilflingseder, 2013, miRNA profiling discriminates types of rejection and injury in human renal allografts, Transplantation, 95835 Lopez, 2015, Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing, BMC Med Genomics, 8, 35, 10.1186/s12920-015-0109-x Sui, 2008, Microarray analysis of MicroRNA expression in acute rejection after renal transplantation, Transpl Immunol, 19, 81, 10.1016/j.trim.2008.01.007 Anglicheau, 2009, MicroRNA expression profiles predictive of human renal allograft status, Proc Natl Acad Sci U S A, 106, 5330, 10.1073/pnas.0813121106 Danger, 2013, Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection, PLoS One, 8, e60702, 10.1371/journal.pone.0060702 Matz, 2016, Identification of T cell-mediated vascular rejection after kidney transplantation by the combined measurement of 5 specific MicroRNAs in blood, Transplantation, 100, 898, 10.1097/TP.0000000000000873 Maluf, 2014, The urine microRNA profile may help monitor post-transplant renal graft function, Kidney Int, 85, 439, 10.1038/ki.2013.338 Lorenzen, 2011, Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients, Am J Transplant, 11, 2221, 10.1111/j.1600-6143.2011.03679.x Liu, 2015, MicroRNA-10b downregulation mediates acute rejection of renal allografts by derepressing BCL2L11, Exp Cell Res, 333, 155, 10.1016/j.yexcr.2015.01.018 Wang, 2013, Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation, J Cardiothorac Surg, 8, 165, 10.1186/1749-8090-8-165 Singh, 2015, Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy, J Heart Lung Transplant, 34, 1376, 10.1016/j.healun.2015.06.008 Duong Van Huyen, 2014, MicroRNAs as non-invasive biomarkers of heart transplant rejection, Eur Heart J, 35, 3194, 10.1093/eurheartj/ehu346 Ben-Dov, 2012, MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis, Transplantation, 941086 Scian, 2011, MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA, Am J Transplant, 11, 2110, 10.1111/j.1600-6143.2011.03666.x Saikumar, 2012, Expression, circulation, and excretion profile of microRNA-21, −155, and -18a following acute kidney injury, Toxicol Sci, 129, 256, 10.1093/toxsci/kfs210 Xu, 2015, Serum miRNA-338-5p, soluble B-cell-activating factor, Allo-antibodies, and renal transplantation, Transplant Proc, 47, 337, 10.1016/j.transproceed.2014.11.030 Sukma Dewi, 2013, Altered serum miRNA profiles during acute rejection after heart transplantation: potential for non-invasive allograft surveillance, J Heart Lung Transplant, 32, 463, 10.1016/j.healun.2012.12.007 Van Aelst, 2016, RNA profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection, Am J Transplant, 16, 99, 10.1111/ajt.13421 Liese, 2016, A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after livertransplantation, Transpl Int, 29, 369, 10.1111/tri.12733 Ng, 2016, Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation, Oncotarget, 7, 19825, 10.18632/oncotarget.7627 Morita, 2016, Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation, Liver Transpl, 22, 665, 10.1002/lt.24400 Tan, 2015, miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma, Clin Res Hepatol Gastroenterol, 3, 359, 10.1016/j.clinre.2014.09.010 Sugimachi, 2015, Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation, Br J Cancer, 112, 532, 10.1038/bjc.2014.621 Asaoka, 2015, Clinical significance of intragraft miR-122 and −155 expression after liver transplantation, Hepatol Res, 45, 898, 10.1111/hepr.12424 Asaoka, 2012, MicroRNA signature of intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies, Am J Transplant, 12, 458, 10.1111/j.1600-6143.2011.03807.x